Inventor · disambiguated record
Laman Alani
Also filed as: ALANI LAMAN · ALANI LAMAN L · ALANI LAMAN LYNN
34 granted patents·21 pending applications·206 citations·filing 1998–2024
97Inventor score
Top patents by PatentIndex Score
55 records- 0197US8377474B2Controlled release formulations of levodopa and uses thereofIMPAX LABORATORIES INC·Filed 2008·Granted Feb 19, 2013·48 cites·82 claims
- 0295US8268349B2Solid pharmaceutical dosage formROSENBERG JOERG·Filed 2012·Granted Sep 18, 2012·15 cites·7 claims
- 0393US10689438B2Stable protein solution formulation containing high concentration of an anti-VEGF antibodyNOVARTIS AG·Filed 2015·Granted Jun 23, 2020·11 cites·18 claims
- 0490US8791154B2High concentration olopatadine ophthalmic compositionGAMACHE DANIEL A·Filed 2012·Granted Jul 29, 2014·28 cites·27 claims
- 0590US7432294B2Pharmaceutical formulationsABBOTT LAB·Filed 2006·Granted Oct 7, 2008·5 cites·25 claims
- 0689US11752096B2Targeted delivery of anti-CSF1R antibodies to joints with tenosynovial giant cell tumorsAMMAX BIO INC·Filed 2022·Granted Sep 12, 2023·1 cites·18 claims
- 0789US8557283B2Controlled release formulations of levodopa and uses thereofHSU ANN·Filed 2012·Granted Oct 15, 2013·9 cites·9 claims
- 0889US8377952B2Solid pharmaceutical dosage formulationABBOTT LAB·Filed 2005·Granted Feb 19, 2013·4 cites·35 claims
- 0988US11419822B2High concentration formulations of anti-CSF1 and anti-CSF1R antibodiesAMMAX BIO INC·Filed 2021·Granted Aug 23, 2022·1 cites·13 claims
- 1088US9089608B2Controlled release formulations of levodopa and uses thereofIMPAX LABORATORIES INC·Filed 2013·Granted Jul 28, 2015·6 cites·21 claims
- 1188US8399015B2Solid pharmaceutical dosage formROSENBERG JOERG·Filed 2011·Granted Mar 19, 2013·3 cites·31 claims
- 1288US8025899B2Solid pharmaceutical dosage formABBOTT LAB·Filed 2004·Granted Sep 27, 2011·14 cites·14 claims
- 1386US9089607B2Controlled release formulations of levodopa and uses thereofIMPAX LABORATORIES INC·Filed 2013·Granted Jul 28, 2015·5 cites·56 claims
- 1484US8691878B2Solid pharmaceutical dosage formABBVIE INC·Filed 2012·Granted Apr 8, 2014·2 cites·20 claims
- 1584US8454998B2Controlled release formulations of levodopa and uses thereofHSU ANN·Filed 2012·Granted Jun 4, 2013·5 cites·30 claims
- 1682US9463246B2Controlled release formulations of levodopa and uses thereofIMPAX LABORATORIES INC·Filed 2013·Granted Oct 11, 2016·3 cites·54 claims
- 1782US8333990B2Solid pharmaceutical dosage formROSENBERG JOERG·Filed 2010·Granted Dec 18, 2012·1 cites·23 claims
- 1880US7141593B1Pharmaceutical formulationsABBOTT LAB·Filed 2000·Granted Nov 28, 2006·10 cites·26 claims
- 1980US2025073170A1High concentration formulations of anti-csf1 and anti-csf1r antibodiesAMMAX BIO INC·Filed 2024·Application pending·0 cites
- 2078US6911214B2Flavoring systems for pharmaceutical compositions and methods of making such compositionsABBOTT LAB·Filed 2001·Granted Jun 28, 2005·6 cites·1 claims
- 2178US6284767B1Retroviral protease inhibiting compoundsABBOTT LAB·Filed 1998·Granted Sep 4, 2001·14 cites·98 claims
- 2277US12178915B2High concentration formulations of anti-CSF1 and anti-CSF1R antibodiesAMMAX BIO INC·Filed 2022·Granted Dec 31, 2024·0 cites·10 claims
- 2377US8486983B2Self-emulsifying formulations of CETP inhibitorsSHETH AGAM R·Filed 2006·Granted Jul 16, 2013·6 cites·7 claims
- 2476US8414921B2Pharmaceutical compositions of combinations of dipeptidyl peptidase-4 inhibitors with metforminKAMALI ASHKAN·Filed 2006·Granted Apr 9, 2013·6 cites·28 claims
- 2574US12371501B2Extended local release of anti-CSFR1 antibodiesAMMAX BIO INC·Filed 2022·Granted Jul 29, 2025·0 cites·11 claims
- 2674US7981911B2Pharmaceutical formulationsABBOTT LAB·Filed 2008·Granted Jul 19, 2011·1 cites·14 claims
- 2772US2024016730A1Targeted delivery of anti-csf1r antibodiesAMMAX BIO INC·Filed 2023·Application pending·0 cites
- 2872US2014179721A1Solid pharmaceutical dosage formABBVIE INC·Filed 2014·Application pending·0 cites
- 2971US12049495B2Stable protein solution formulation containing high concentration of an anti-VEGF antibodyNOVARTIS AG·Filed 2020·Granted Jul 30, 2024·0 cites·14 claims
- 3071US11427641B2Extended local release of anti-CSFR1 antibodiesAMMAX BIO INC·Filed 2022·Granted Aug 30, 2022·0 cites·5 claims
- 3171US2008299203A1Solid Pharmaceutical Dosage FormulationROSENBERG JOERG·Filed 2008·Application pending·0 cites
- 3270US8501219B2Flavoring systems for pharmaceutical compositions and methods of making such compositionsALANI LAMAN·Filed 2010·Granted Aug 6, 2013·2 cites·29 claims
- 3368US8895051B2Flavoring systems for pharmaceutical compositions and methods of making such compositionsABBVIE INC·Filed 2013·Granted Nov 25, 2014·0 cites·31 claims
- 3465US9901640B2Controlled release formulations of levodopa and uses thereofIMPAX LABORATORIES INC·Filed 2016·Granted Feb 27, 2018·0 cites·25 claims
- 3565US8309613B2Solid pharmaceutical dosage formROSENBERG JOERG·Filed 2010·Granted Nov 13, 2012·0 cites·18 claims
- 3663US2007249643A1Solid pharmaceutical dosage formROSENBERG JOERG·Filed 2007·Application pending·0 cites
- 3762US2013004578A1Solid Pharmaceutical Dosage FormulationABBVIE INC·Filed 2012·Application pending·0 cites
- 3861US9533046B2Controlled release formulations of levodopa and uses thereofIMPAX LABORATORIES INC·Filed 2015·Granted Jan 3, 2017·0 cites·31 claims
- 3961US9533053B2High concentration olopatadine ophthalmic compositionALCON RES LTD·Filed 2014·Granted Jan 3, 2017·0 cites·13 claims
- 4060US2024199752A1Treatment of ophthalmic diseasesJOHNSON KIRK WILLIAM·Filed 2022·Application pending·0 cites
- 4158US2011165239A1Pharmaceutical compositions of atorvastatinALANI LAMAN·Filed 2009·Application pending·0 cites
- 4257US2008181948A1Solid pharmaceutical dosage formulationsABBOTT LAB·Filed 2007·Application pending·0 cites
- 4356US2023000945A1Topical pharmaceutical formulations of a cyclic depsipeptideLIFEMAX LABORATORIES INC·Filed 2022·Application pending·0 cites
- 4455US2005191324A1Flavoring systems for pharmaceutical compositions and methods of making such compositionsFiled 2005·Application pending·0 cites
- 4550US9504691B2Finafloxacin suspension compositionsALCON RES LTD·Filed 2013·Granted Nov 29, 2016·0 cites·12 claims
- 4650US2017071895A1High Concentration Olopatadine Ophthalmic CompositionALCON RES LTD·Filed 2016·Application pending·0 cites
- 4749US2005107446A1Pharmaceutical compositions of amlodipine and atorvastatinFiled 2004·Application pending·0 cites
- 4845US2008145430A1Ophthalmic Nanoparticulate Formulation Of A Cyclooxygenase-2 Selective InhibitorPANMAI SANTIPHARP·Filed 2005·Application pending·0 cites
- 4945US2013064896A1Gastroretentive Solid Oral Dosage Forms with Swellable Hydrophilic PolymerALANI LAMAN LYNN·Filed 2010·Application pending·0 cites
- 5044US2005048112A1Solid pharmaceutical dosage formFiled 2003·Application pending·0 cites
Showing the top 50 of 55 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Laman Alani files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →